35 Results

People

  1. Shah
    Shah
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Devlin
    Devlin
  5. Scordo
    Scordo
  6. Dahi
    Dahi
  7. Sauter
    Sauter
  8. Chung
    Chung
  9. Landau
    Landau
  10. Maloy
    Maloy

Groups

  1. Bone Marrow Transplant (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. Hematologic Malignancies, Division of (35)
  5. Survivorship Research (35)
  6. CTCR Scholars (26)
  7. Epidemiology and Biostatistics (21)
  8. Biostatistics Service (20)
  9. MSK Grad Students (19)
  10. Master of Science in Clinical and Translational Cancer Research (18)
  1. "article"
  2. "Gunjan Shah"
Formats
  1. Journal Article (33)
  2. Review (2)
Groups
  1. Bone Marrow Transplant (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. Hematologic Malignancies, Division of (35)
  5. Survivorship Research (35)
  6. CTCR Scholars (26)

More Groups

People
  1. Gunjan Shah (35)
  2. Miguel-Angel Perales (22)
  3. Sergio Giralt (22)
  4. Michael Scordo (18)
  5. Sean Devlin (18)
  6. Parastoo Dahi (13)

More People

Years
  1. 2024 (1)
  2. 2023 (9)
  3. 2022 (5)
  4. 2021 (3)
  5. 2020 (7)
  6. 2019 (1)

More Years

Publications
  1. Transplantation and Cellular Therapy (7)
  2. Biology of Blood and Marrow Transplantation (5)
  3. Blood Advances (5)
  4. Blood (3)
  5. Blood Cancer Journal (2)
  6. British Journal of Haematology (2)

More Publications

Publishers
  1. Elsevier Inc. (13)
  2. American Society of Hematology (8)
  3. Nature Publishing Group (3)
  4. John Wiley & Sons (2)
  5. Taylor & Francis Group (2)
  6. American Medical Association (1)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
    Journal Article

    Elias, S.; Brown, S.; Devlin, S. M.; Barker, J. N.; Cho, C.; Chung, D. J.; Dahi, P. B.; Giralt, S.; Gyurkocza, B.; Jakubowski, A. A.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
    Journal Article

    Merrill, M. H.; Dahi, P. B.; Redd, R. A.; McDonough, M. M.; Chen, Y. B.; DeFilipp, Z.; Herrera, A. F.; Fisher, D. C.; LaCasce, A. S.; Odejide, O. O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Patient characteristics and outcomes of outpatient tisagenlecleucel recipients for B cell non-Hodgkin lymphoma
    Review

    Ahmed, N.; Wesson, W.; Mushtaq, M. U.; Porter, D. L.; Nasta, S. D.; Brower, J.; Bachanova, V.; Hu, M.; Nastoupil, L. J.; Oluwole, O. O.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation after chimeric antigen receptor T cell therapy in large B cell lymphoma
    Journal Article

    Fried, S.; Shouval, R.; Walji, M.; Flynn, J. R.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Tomas, A. A.; Fein, J. A.; Devlin, S. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
    Journal Article

    Van Oekelen, O.; Nath, K.; Mouhieddine, T. H.; Farzana, T.; Aleman, A.; Melnekoff, D. T.; Ghodke-Puranik, Y.; Shah, G. L.; Lesokhin, A.; Giralt, S.; more...
    Blood (2023)

    Fulltext@MSK | Save